What the hell happened to the beautiful fusion protein?

What the hell happened to our dear Belatacept? What is the long term plan? Is ANYONE using this?

 

Not much, the indication is pretty narrow. Not too many patients with post transplant lymphoproliferative disorder.

 

Oxford Journals
Medicine & Health
Nephrology Dialysis Transplantation
Volume 25, Issue 7
Pp. 2089-2098.


The incidence of PTLD, ranging from 1% to 20%, clearly relates to the type of transplanted organ, IS, underlying disease, age, viral infections including EBV, cytomegalovirus and hepatitis C virus (HCV), and length of post-transplant follow-up. Although the occurrence decreases after the first post-transplant year, the cumulative incidence increases with the time elapsed since transplantation. The highest incidence from 5% to 20% is reported following lung and intestinal transplantation; in contrast, renal transplant recipients (RTRs) have an incidence of 1–3%. In liver transplant recipients, the occurrence ranges from 2% to 10%, from 2–3% in adults to 10% in children.

 

This is not my beautiful fusion protein...
My God!
How did I get HERE?!?